Transcription factors in the pathogenesis of pulmonary arterial hypertension-Current knowledge and therapeutic potential.

Körbelin, Jakob; Klein, Julius; Matuszcak, Christiane; Runge, Johannes; Harbaum, Lars; Klose, Hans; Hennigs, Jan K

Körbelin, Jakob; Klein, Julius; Matuszcak, Christiane; Runge, Johannes; Harbaum, Lars; Klose, Hans; Hennigs, Jan K.

Afiliação

Körbelin J; ENDomics Lab, Department of Medicine, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Klein J; ENDomics Lab, Department of Medicine, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Matuszcak C; Division of Pneumology and Center for Pulmonary Arterial Hypertension Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Runge J; ENDomics Lab, Department of Medicine, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Harbaum L; Division of Pneumology and Center for Pulmonary Arterial Hypertension Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Klose H; ENDomics Lab, Department of Medicine, Center of Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Hennigs JK; Division of Pneumology and Center for Pulmonary Arterial Hypertension Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Front Cardiovasc Med ; 9: 1036096, 2022.

Article em En | MEDLINE | ID: mdl-36684555

Palavras-chave

epigenetics; epigenetics (chromatin remodeling); pathogenesis; pulmonary hypertension (PAH); reverse remodeling; targeted therapy; transcriptomics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google